| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/11/2011 | US20110196011 Substituted arylpyrazoles |
| 08/11/2011 | US20110196010 Crystalline chemotherapeutic |
| 08/11/2011 | US20110196009 INHIBITORS OF Akt ACTIVITY |
| 08/11/2011 | US20110196008 Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof |
| 08/11/2011 | US20110196007 Monocyclic cyanoenones and methods of use thereof |
| 08/11/2011 | US20110196005 Antagonists of lysophosphatidic acid receptors |
| 08/11/2011 | US20110196004 Crystalline forms of (r) -5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz [z] ylidene] -2-( [z]-propylimino) -3-0-tolyl-thiazolidin-4-one |
| 08/11/2011 | US20110196003 Tricyclic compound and pharmaceutical use thereof |
| 08/11/2011 | US20110196002 Diacylglycerol acyltransferase inhibitors |
| 08/11/2011 | US20110195999 Novel antifungal agent containing heterocyclic compound |
| 08/11/2011 | US20110195997 Dicarboxamide Derivatives |
| 08/11/2011 | US20110195996 Transmucosal Treatment Methods in Patients With Mucositis |
| 08/11/2011 | US20110195995 Methods of Optimizing Treatment of Estrogen-Receptor Positive Breast Cancers |
| 08/11/2011 | US20110195994 Piperidinyl GPCR Agonists |
| 08/11/2011 | US20110195993 Ppar agonist compounds, preparation and uses |
| 08/11/2011 | US20110195992 New compounds ii |
| 08/11/2011 | US20110195991 3-aminoimidazo [1,2-a] pyridine derivatives as sglt inhibitors |
| 08/11/2011 | US20110195990 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 08/11/2011 | US20110195989 Controlled Release Formulations of Opioids |
| 08/11/2011 | US20110195988 Pharmaceutical Composition |
| 08/11/2011 | US20110195987 Treatment with cholinergic agonists |
| 08/11/2011 | US20110195986 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 08/11/2011 | US20110195985 Compounds for the treatment of lysosomal storage diseases |
| 08/11/2011 | US20110195983 Quinazolinone derivatives useful as vanilloid antagonists |
| 08/11/2011 | US20110195982 Predictive marker for egfr inhibitor treatment |
| 08/11/2011 | US20110195981 Methods and dosage forms for reducing side effects of benzisozazole derivatives |
| 08/11/2011 | US20110195980 Bicyclic Kinase Inhibitors |
| 08/11/2011 | US20110195979 Compounds for the treatment and prevention of influenza |
| 08/11/2011 | US20110195978 Compounds for treatment of alzheimer's disease |
| 08/11/2011 | US20110195977 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition |
| 08/11/2011 | US20110195976 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol |
| 08/11/2011 | US20110195975 Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 08/11/2011 | US20110195974 Methods of treating inflammatory conditions with adrenergic antagonists |
| 08/11/2011 | US20110195973 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity |
| 08/11/2011 | US20110195972 Application of 2,5 -dihydroxymethyl -3,6 - dimethyl pyrazine and its derivates in pharmacy |
| 08/11/2011 | US20110195971 Methods of identifying responders to dopamine agonist therapy |
| 08/11/2011 | US20110195970 Methods of identifying and treating responders to dopamine agonist therapy |
| 08/11/2011 | US20110195969 Amide compounds as boosters of antivirals |
| 08/11/2011 | US20110195967 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 08/11/2011 | US20110195966 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor |
| 08/11/2011 | US20110195965 Tetrahydro- and dihydroquinazolinones |
| 08/11/2011 | US20110195964 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 08/11/2011 | US20110195963 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 08/11/2011 | US20110195962 Use of multi-pharmacophore compounds to treat nasal disorders |
| 08/11/2011 | US20110195961 Tricyclic oxazolidinone antibiotic compounds |
| 08/11/2011 | US20110195960 Inhibitors of c-fms kinase |
| 08/11/2011 | US20110195959 Compositions And Methods Relating To Novel Compounds And Targets Thereof |
| 08/11/2011 | US20110195958 Activators of human pyruvate kinase |
| 08/11/2011 | US20110195957 Substituted diazepan orexin receptor antagonists |
| 08/11/2011 | US20110195956 Heterocyclic Kinase Inhibitors |
| 08/11/2011 | US20110195955 Highly selective sigma receptor ligands |
| 08/11/2011 | US20110195954 Novel compounds |
| 08/11/2011 | US20110195953 Compositions and methods for treating cns disorders |
| 08/11/2011 | US20110195952 Treating psychological conditions using muscarinic receptor m1 antagonists |
| 08/11/2011 | US20110195951 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
| 08/11/2011 | US20110195950 Organic Compounds |
| 08/11/2011 | US20110195949 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents |
| 08/11/2011 | US20110195948 Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors |
| 08/11/2011 | US20110195947 Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same |
| 08/11/2011 | US20110195945 Compounds, Compositions and Methods for Treating or Preventing Hypoxic or Ischemic Injury |
| 08/11/2011 | US20110195944 Modified release emulsions for application to skin or vaginal mucosa |
| 08/11/2011 | US20110195943 Napadisylate salt of 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one as agonist of the beta 2 adrenergic receptor |
| 08/11/2011 | US20110195942 Method of making and using 7alpha, 11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate |
| 08/11/2011 | US20110195941 Methods of Use To Orally and Topically Treat Acne and Other Skin Conditions By Administering a 19-NOR Containing Vitamin D Analog With or Without a Retinoid |
| 08/11/2011 | US20110195940 Protease Inhibitors Having Enhanced Features |
| 08/11/2011 | US20110195939 Antitumor properties of no modified protease inhibitors |
| 08/11/2011 | US20110195937 Oxidized thiophospholipid compounds and uses thereof |
| 08/11/2011 | US20110195936 Bicyclic sphingosine 1-phosphate analogs |
| 08/11/2011 | US20110195935 Nitric oxide releasing amino acid ester compound, composition and method of use |
| 08/11/2011 | US20110195934 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
| 08/11/2011 | US20110195933 Pyrazolo[1,5-a]pyridines as mark inhibitors |
| 08/11/2011 | US20110195932 Drug Combinations for the Treatment of Duchenne Muscular Dystrophy |
| 08/11/2011 | US20110195931 Methods and compositions for reducing neuronal cell death |
| 08/11/2011 | US20110195929 Compounds for the treatment of flaviviral infections |
| 08/11/2011 | US20110195928 Administration of Copper to an Animal |
| 08/11/2011 | US20110195927 Compositions Comprising Polymers Having Amino Sugar Units and Methods of Making and Using Same |
| 08/11/2011 | US20110195926 Purified beta glucan composition |
| 08/11/2011 | US20110195925 Sterile Hyaluronic Acid Solutions |
| 08/11/2011 | US20110195924 Methods of Inhibiting the Interaction Between S100P and the Receptor for Advanced Glycation End-Products |
| 08/11/2011 | US20110195923 Methods for Predicting the Response to Anti-Cancer Treatment with an Agonist of TLR7 or an Agonist of TLR8 |
| 08/11/2011 | US20110195922 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B |
| 08/11/2011 | US20110195921 Elimination of a contaminating non-human sialic acid by metabolic competition |
| 08/11/2011 | US20110195920 Biodefenses using triazole-containing macrolides |
| 08/11/2011 | US20110195919 Combination therapy for acne vulgaris comprising administration of adapalene 0.3% gel and clindamycin/benzoyl peroxide gel |
| 08/11/2011 | US20110195918 Method for producing pectin hydrolysis products |
| 08/11/2011 | US20110195917 Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivate |
| 08/11/2011 | US20110195915 Method of inhibiting prostate cancer cell proliferation |
| 08/11/2011 | US20110195911 Synthetic analogs of the juxtamembrane domain of igf1r and uses thereof |
| 08/11/2011 | US20110195910 Use of tocotrienol composition for the prevention of cancer |
| 08/11/2011 | US20110195907 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 08/11/2011 | US20110195903 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 08/11/2011 | US20110195470 Production of Isoprenoids |
| 08/11/2011 | US20110195456 Methods and compositions for the production of monoclonal antibodies |
| 08/11/2011 | US20110195403 Systems and methods for fertility analysis |
| 08/11/2011 | US20110195156 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 08/11/2011 | US20110195138 Anti-inflammatory cranberry flavonol extract preparations |
| 08/11/2011 | US20110195137 Dermo-cosmetic composition for pets |
| 08/11/2011 | US20110195133 Dermcidin-derived peptides for lung cancer diagnostics |
| 08/11/2011 | US20110195128 Treating or preventing gout |
| 08/11/2011 | US20110195127 Compositions and methods for silencing apolipoprotein b |